The French Competition Authority launches a vast sector-specific inquiry on the functioning of competition in the medicinal products and medical biology sectors

As part of its advisory powers, the Autorité de la concurrence is launching a vast sector-specific inquiry on the functioning of competition in the medicinal products and medical biology sectors.* In particular it will look at the distribution of pharmaceuticals, their price regulation mechanism, as well as at the business development opportunities available to pharmacists. In its opinion, the Autorité will make any recommendations, in accordance with public health matters, likely to stimulate competition. Background The importance of the healthcare sector in the national economy and constant developments in the sector have prompted the Autorité de la concurrence to take a regular interest in it. In addition to litigation decisions, like those sanctioning certain practices carried out

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

French Competition Authority, The French Competition Authority launches a vast sector-specific inquiry on the functioning of competition in the medicinal products and medical biology sectors, 20 November 2017, e-Competitions Bulletin November 2017, Art. N° 85361

Visites 46

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues